MedPath

Study of medication timing of levocetirizine dihydrochloride in patients with recalcitrant chronic urticaria to anti-histamine drug

Not Applicable
Conditions
Chronic urticaria
Registration Number
JPRN-UMIN000013777
Lead Sponsor
Department of Dermatology, Kurume University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with acute infectious disease 2. Patients who are treated with ultra-violet therapy or hyposensitization therapy 3. Patients who engaged in dangerous job such as driving a car 4. Patients who were treated with systemic steroids less than 2 weeks prior to the initiation of this study 5. Patients who are pregnant or has possibility to be pregnant, and who are lactating 6. Patients who suffered from grave liver, renal, or heart disease 7. Patients who do not have hypertension, diabetes mellitus, or collagen disease 8. Patients who are considered inappropriate to be enrolled in this study by the doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
degree of pruritus
Secondary Outcome Measures
NameTimeMethod
adverse event
© Copyright 2025. All Rights Reserved by MedPath